Sign In
Buy ZYXI
$0.125
+0 (+0%)
At Close: Mar 20, 2026
VA Spending on Hospital and Medical Care Exceeds $112 Billion Annually ENGLEWOOD, Colo. , Dec. 17, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI) ("Zynex", "ZMS", "we" or the "Company"), an innovati
Zynex CEO outlines plans for 2025 after revenue milestone – ICYMI
04:36pm, Friday, 13'th Dec 2024
Zynex Inc (NASDAQ:ZYXI) CEO Thomas Sandgaard spoke with Proactive about the company's 2024 achievements and plans for 2025. Zynex reached $200 million in revenue while staying profitable, thanks to em
Zynex UCSF Study Results Demonstrate Laser Technology Benefits in Resolving Racial Bias of Current LED Pulse Oximeters
09:15am, Thursday, 12'th Dec 2024
ENGLEWOOD, Colo. , Dec. 12, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI) ("Zynex", "ZMS", "we" or the "Company"), an innovative medical technology company specializing in the manufacture and sale
ZYXI Stock Gains on the Completion of NiCO's Clinical Verification Trial
01:21pm, Monday, 09'th Dec 2024
Zynex announces the completion of the clinical verification trial of its NiCO pulse oximeter.
Zynex Announces Completion of Its Laser Pulse Oximetry Trial
09:15am, Thursday, 05'th Dec 2024
ENGLEWOOD, Colo. , Dec. 5, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI) ("Zynex", "ZMS", "we" or the "Company"), an innovative medical technology company specializing in the manufacture and sale o
Zynex joins Open Oximetry Project as it advances innovative NiCO pulse oximeter
10:12am, Tuesday, 03'rd Dec 2024
Zynex Inc (NASDAQ:ZYXI) has announced its membership in the Collaborative Community of the Open Oximetry Project as an industry member. This initiative, led by the University of California, San Franci
Zynex Announces Open Oximetry Project Membership
09:15am, Tuesday, 03'rd Dec 2024
ENGLEWOOD, Colo. , Dec. 3, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI) ("Zynex", "ZMS", "we" or the "Company"), an innovative medical technology company specializing in the manufacture and sale o
Zynex leverages multi-modality NexWave device to transform pain management
03:42pm, Tuesday, 26'th Nov 2024
Zynex Inc (NASDAQ:ZYXI) holds a competitive niche in the pain management market, benefiting from its focus on non-invasive, reimbursable solutions. While the company has successfully capitalized on t
Zynex, Inc. (ZYXI) Q3 2024 Earnings Call Transcript
06:53pm, Thursday, 24'th Oct 2024
Zynex, Inc. (NASDAQ:ZYXI ) Q3 2024 Earnings Conference Call October 24, 2024 4:15 PM ET Company Participants Quinn Callanan - IR Thomas Sandgaard - Chairman, President and CEO Dan Moorhead - CFO Donal
Zynex Inc. (ZYXI) Tops Q3 Earnings Estimates
06:11pm, Thursday, 24'th Oct 2024
Zynex Inc. (ZYXI) came out with quarterly earnings of $0.07 per share, beating the Zacks Consensus Estimate of $0.05 per share. This compares to earnings of $0.10 per share a year ago.
Zynex sees pain management orders increase in Q3 following FDA approval
04:50pm, Thursday, 24'th Oct 2024
Zynex Inc (NASDAQ:ZYXI) announced its third-quarter 2024 financial and operational results highlighted by a 13% year-over-year increase in orders. The pain management device company reported net reven
Zynex Reports Third Quarter 2024 Financial Results
04:01pm, Thursday, 24'th Oct 2024
ENGLEWOOD, Colo. , Oct. 24, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain
Sales, strategy, and saving lives: A conversation with Zynex CEO Thomas Sandgaard
11:32am, Thursday, 24'th Oct 2024
Thomas Sandgaard is just getting started. The enigmatic “rockstar CEO” of pain management company Zynex Inc (NASDAQ:ZYXI) has worn many hats throughout his career: Sales leader, lead guitarist, fo
Zynex Sets Third Quarter 2024 Earnings Call
09:15am, Wednesday, 16'th Oct 2024
ENGLEWOOD, Colo. , Oct. 16, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain
Zynex's strategic shifts set stage for long-term success, analysts say
03:09pm, Monday, 16'th Sep 2024
Analysts expect Zynex Inc (NASDAQ:ZYXI) to return to stronger growth in 2025, driven by product diversification, sales force expansion, and upcoming product launches. The company's strategic initiativ
